CINV — Crucial Innovations Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Crucial Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0 | 0 | 0 | 0 | 0.053 |
| Net Total Receivables | — | — | — | — | 0.016 |
| Prepaid Expenses | |||||
| Total Current Assets | 0 | 0.011 | 0 | 0 | 0.068 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | — | 0 | 0.068 | 0.023 |
| Total Assets | 0 | 0.011 | 0 | 0.068 | 0.092 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0 | 0.034 | 0.04 | 0.114 | 1.87 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0 | 0.034 | 0.04 | 0.114 | 1.87 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0 | -0.023 | -0.04 | -0.046 | -1.78 |
| Total Liabilities & Shareholders' Equity | 0 | 0.011 | 0 | 0.068 | 0.092 |
| Total Common Shares Outstanding |